GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » ZimVie Inc (NAS:ZIMV) » Definitions » EV-to-EBITDA
中文

ZimVie (ZimVie) EV-to-EBITDA

: 9.58 (As of Today)
View and export this data going back to 2022. Start your Free Trial

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, ZimVie's enterprise value is $872.3 Mil. ZimVie's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 was $91.1 Mil. Therefore, ZimVie's EV-to-EBITDA for today is 9.58.

The historical rank and industry rank for ZimVie's EV-to-EBITDA or its related term are showing as below:

ZIMV' s EV-to-EBITDA Range Over the Past 10 Years
Min: 3.7   Med: 8.15   Max: 10.99
Current: 9.58

During the past 6 years, the highest EV-to-EBITDA of ZimVie was 10.99. The lowest was 3.70. And the median was 8.15.

ZIMV's EV-to-EBITDA is ranked better than
68.92% of 489 companies
in the Medical Devices & Instruments industry
Industry Median: 14.89 vs ZIMV: 9.58

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-04-23), ZimVie's stock price is $15.925. ZimVie's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was $-14.880. Therefore, ZimVie's PE Ratio for today is At Loss.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.


ZimVie EV-to-EBITDA Historical Data

The historical data trend for ZimVie's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ZimVie Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-EBITDA
Get a 7-Day Free Trial - - - 9.12 10.22

ZimVie Quarterly Data
Dec18 Dec19 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
EV-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 9.12 7.15 8.05 7.38 10.22

Competitive Comparison

For the Medical Devices subindustry, ZimVie's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


ZimVie EV-to-EBITDA Distribution

For the Medical Devices & Instruments industry and Healthcare sector, ZimVie's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where ZimVie's EV-to-EBITDA falls into.



ZimVie EV-to-EBITDA Calculation

ZimVie's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=872.344/91.072
=9.58

ZimVie's current Enterprise Value is $872.3 Mil.
ZimVie's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $91.1 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


ZimVie  (NAS:ZIMV) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

ZimVie's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=15.925/-14.880
=At Loss

ZimVie's share price for today is $15.925.
ZimVie's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-14.880.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?


ZimVie EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of ZimVie's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


ZimVie (ZimVie) Business Description

Traded in Other Exchanges
Address
10225 Westmoor Drive, Westminster, CO, USA, 80021
ZimVie Inc is focused on the dental and spine markets and their respective growth drivers such as implants, surgical tools, bone graft substitutes, spinal fusion implants, non-fusion alternatives, and digital care management solutions. Business is organized into two operating segments the spine products segment and the dental products segment.
Executives
Camber Capital Management Lp 10 percent owner 101 HUNTINGTON AVENUE, SUITE 2101, BOSTON MA 02199
Sally Crawford director C/O HOLOGIC, INC., BEDFORD MA 01730
Vafa Jamali director, officer: See Remarks C/O ZIMVIE INC., 10225 WESTMOOR DRIVE, WESTMINSTER CO 80021
Richard Heppenstall officer: See Remarks C/O ZIMVIE INC., 10225 WESTMOOR DRIVE, WESTMINSTER CO 80021
Zimmer Biomet Holdings, Inc. 10 percent owner 345 EAST MAIN STREET, WARSAW IN 46580
Richard Kuntz director MEDTRONIC, INC., 710 MEDTRONIC PWKY MS LC 310, MINNEAPOLIS MN 55432
Vinit K Asar director 10910 DOMAIN DRIVE, SUITE 300, AUSTIN TX 78758
Karen Matusinec director C/O ZIMVIE INC., 10225 WESTMOOR DRIVE, WESTMINSTER CO 80021
David P King director PRIVIA HEALTH GROUP, INC., 950 N. GLEBE RD., SUITE 700, ARLINGTON VA 22203
Rebecca Ann Whitney officer: See Remarks 10225 WESTMOOR DRIVE, WESTMINSTER CO 80021
David John Harmon officer: See Remarks 10225 WESTMOOR DRIVE, WESTMINSTER CO 80021
Indraneel Kanaglekar officer: See Remarks C/O ZIMVIE INC., 10225 WESTMOOR DRIVE, WESTMINSTER CO 80021
Heather Kidwell officer: See Remarks C/O ZIMVIE INC., 10225 WESTMOOR DRIVE, WESTMINSTER CO 80021
Sandra Schneider officer: Chief Accounting Officer C/O ZIMVIE INC., 10225 WESTMOOR DRIVE, WESTMINSTER CO 80021